Oil prices jumped on Monday to their highest since January as the United States' weekend move to join Israel in attacking ...

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for ...

Shares of Gilead rose nearly 3% after the U.S. Supreme Court on Friday preserved a key element of the Obamacare law that ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

Bill Gates has responded to a video posted by Senator Susan Collins (R-ME) regarding the President's Emergency Plan for AIDS Relief (PEPFAR).

Four gay men in Africa have HIV. And it’s all Trump’s fault. “Trump aid cuts deal a blow to HIV prevention in Africa,” reads a Reuters byline. The outlet scraped together four interviewees who have ...

Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for ...

The FDA announced today that they've approved a twice-yearly injection for preventing HIV infection in adults and kids. News ...

The Obamacare law requires health insurers to provide preventive care, including cancer screenings and HIV prevention ...

Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.